Split History
ETFs Holding GALT »    GALT Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death). According to our GALT split history records, Galectin Therapeutics has had 2 splits.
GALT split history picture
Galectin Therapeutics (GALT) has 2 splits in our GALT split history database. The first split for GALT took place on September 20, 1999. This was a 2 for 1 split, meaning for each share of GALT owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. GALT's second split took place on March 23, 2012. This was a 1 for 6 reverse split, meaning for each 6 shares of GALT owned pre-split, the shareholder now owned 1 share. For example, a 2000 share position pre-split, became a 333.333333333333 share position following the split.

When a company such as Galectin Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as Galectin Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the GALT split history from start to finish, an original position size of 1000 shares would have turned into 333.333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Galectin Therapeutics shares, starting with a $10,000 purchase of GALT, presented on a split-history-adjusted basis factoring in the complete GALT split history. GALT split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/24/2014
End date: 07/22/2024
Start price/share: $13.72
End price/share: $2.48
Dividends collected/share: $0.00
Total return: -81.92%
Average Annual Total Return: -15.72%
Starting investment: $10,000.00
Ending investment: $1,807.35
Years: 10.00
Date Ratio
09/20/19992 for 1
03/23/20121 for 6
GALT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

GBSN Split History
GENE Split History
GERN Split History
GILD Split History
GNCA Split History
GNVC Split History
GRFS Split History
GSK Split History
GTS Split History
GTXI Split History

Also explore: GALT shares outstanding history

Email EnvelopeFree GALT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

INNOVATE Corp. (VATE)
Nauticus Robotics, Inc. (KITT)
Benson Hill, Inc. (BHIL)
Scorpius Holdings, Inc (SCPX)
Senti Biosciences, Inc. (SNTI)
Catheter Precision, Inc. (VTAK)
SITE Centers Corp. (SITC)
MGO Global Inc. (MGOL)
Deckers Brands (DECK)
Alzamend Neuro, Inc. (ALZN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

GALT Insider Buying

GALT Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.